Encounter Encounter for symptom 05-15-1941
Condition Chronic sinusitis (disorder) 05-15-1941
Encounter Encounter for problem 07-07-1941
Encounter Encounter for problem 07-20-1941
Encounter Encounter for symptom 04-15-1944
MedicationRequest doxycycline hyclate 100 MG 04-15-1944
Encounter General examination of patient (procedure) 02-24-1959
Condition Hypertension 02-24-1959
Condition Served in armed forces (finding) 02-24-1959
Condition Received higher education (finding) 02-24-1959
MedicationRequest lisinopril 10 MG Oral Tablet 02-24-1959
Encounter Encounter for check up (procedure) 12-22-1959
MedicationRequest lisinopril 10 MG Oral Tablet 12-22-1959
Encounter General examination of patient (procedure) 03-01-1960
MedicationRequest lisinopril 10 MG Oral Tablet 03-01-1960
Encounter Encounter for check up (procedure) 04-12-1960
MedicationRequest lisinopril 10 MG Oral Tablet 04-12-1960
Encounter General examination of patient (procedure) 03-07-1961
MedicationRequest lisinopril 10 MG Oral Tablet 03-07-1961
Encounter General examination of patient (procedure) 03-13-1962
MedicationRequest lisinopril 10 MG Oral Tablet 03-13-1962
Encounter General examination of patient (procedure) 03-19-1963
MedicationRequest lisinopril 10 MG Oral Tablet 03-19-1963
Encounter General examination of patient (procedure) 03-24-1964
MedicationRequest lisinopril 10 MG Oral Tablet 03-24-1964
Encounter General examination of patient (procedure) 03-30-1965
MedicationRequest lisinopril 10 MG Oral Tablet 03-30-1965
Encounter General examination of patient (procedure) 04-05-1966
MedicationRequest lisinopril 10 MG Oral Tablet 04-05-1966
Encounter General examination of patient (procedure) 04-11-1967
MedicationRequest lisinopril 10 MG Oral Tablet 04-11-1967
Encounter General examination of patient (procedure) 04-16-1968
MedicationRequest lisinopril 10 MG Oral Tablet 04-16-1968
Encounter General examination of patient (procedure) 04-22-1969
MedicationRequest lisinopril 10 MG Oral Tablet 04-22-1969
Encounter General examination of patient (procedure) 04-28-1970
MedicationRequest lisinopril 10 MG Oral Tablet 04-28-1970
Encounter General examination of patient (procedure) 05-04-1971
MedicationRequest lisinopril 10 MG Oral Tablet 05-04-1971
Encounter General examination of patient (procedure) 05-09-1972
Condition Body mass index 30+ - obesity (finding) 05-09-1972
MedicationRequest lisinopril 10 MG Oral Tablet 05-09-1972
Encounter General examination of patient (procedure) 05-15-1973
Condition Prediabetes 05-15-1973
Condition Anemia (disorder) 05-15-1973
MedicationRequest lisinopril 10 MG Oral Tablet 05-15-1973
Encounter Encounter for problem 05-15-1973
MedicationRequest lisinopril 10 MG Oral Tablet 05-15-1973
Encounter General examination of patient (procedure) 05-21-1974
MedicationRequest lisinopril 10 MG Oral Tablet 05-21-1974
Encounter General examination of patient (procedure) 05-27-1975
MedicationRequest lisinopril 10 MG Oral Tablet 05-27-1975
Encounter General examination of patient (procedure) 06-01-1976
Condition Opioid abuse (disorder) 06-01-1976
MedicationRequest lisinopril 10 MG Oral Tablet 06-01-1976
Encounter General examination of patient (procedure) 06-07-1977
MedicationRequest lisinopril 10 MG Oral Tablet 06-07-1977
Encounter General examination of patient (procedure) 06-13-1978
MedicationRequest lisinopril 10 MG Oral Tablet 06-13-1978
Encounter Encounter for 'check-up' 06-10-1978
Condition Has a criminal record (finding) 06-13-1978
MedicationRequest lisinopril 10 MG Oral Tablet 06-13-1978
Encounter General examination of patient (procedure) 06-19-1979
MedicationRequest lisinopril 10 MG Oral Tablet 06-19-1979
Encounter General examination of patient (procedure) 06-24-1980
MedicationRequest lisinopril 10 MG Oral Tablet 06-24-1980
Encounter General examination of patient (procedure) 06-30-1981
MedicationRequest lisinopril 10 MG Oral Tablet 06-30-1981
Encounter General examination of patient (procedure) 07-06-1982
MedicationRequest lisinopril 10 MG Oral Tablet 07-06-1982
Encounter General examination of patient (procedure) 07-12-1983
MedicationRequest lisinopril 10 MG Oral Tablet 07-12-1983
Encounter General examination of patient (procedure) 07-17-1984
MedicationRequest lisinopril 10 MG Oral Tablet 07-17-1984
Encounter General examination of patient (procedure) 07-23-1985
MedicationRequest lisinopril 10 MG Oral Tablet 07-23-1985
Encounter General examination of patient (procedure) 07-29-1986
MedicationRequest lisinopril 10 MG Oral Tablet 07-29-1986
Encounter General examination of patient (procedure) 08-04-1987
MedicationRequest lisinopril 10 MG Oral Tablet 08-04-1987
Encounter General examination of patient (procedure) 08-09-1988
Condition Atrial Fibrillation 08-09-1988
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 08-09-1988
MedicationRequest Verapamil Hydrochloride 40 MG 08-09-1988
MedicationRequest Digoxin 0.125 MG Oral Tablet 08-09-1988
MedicationRequest Verapamil Hydrochloride 40 MG 08-09-1988
MedicationRequest lisinopril 10 MG Oral Tablet 08-09-1988
MedicationRequest Digoxin 0.125 MG Oral Tablet 08-09-1988
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 08-09-1988
Encounter Encounter for check up (procedure) 04-18-1989
MedicationRequest Verapamil Hydrochloride 40 MG 04-18-1989
MedicationRequest lisinopril 10 MG Oral Tablet 04-18-1989
MedicationRequest Digoxin 0.125 MG Oral Tablet 04-18-1989
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 04-18-1989
Encounter General examination of patient (procedure) 08-15-1989
MedicationRequest Verapamil Hydrochloride 40 MG 08-15-1989
MedicationRequest lisinopril 10 MG Oral Tablet 08-15-1989
MedicationRequest Digoxin 0.125 MG Oral Tablet 08-15-1989
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 08-15-1989
Encounter General examination of patient (procedure) 08-21-1990
MedicationRequest Verapamil Hydrochloride 40 MG 08-21-1990
MedicationRequest lisinopril 10 MG Oral Tablet 08-21-1990
MedicationRequest Digoxin 0.125 MG Oral Tablet 08-21-1990
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 08-21-1990
Encounter General examination of patient (procedure) 08-27-1991
MedicationRequest Verapamil Hydrochloride 40 MG 08-27-1991
MedicationRequest lisinopril 10 MG Oral Tablet 08-27-1991
MedicationRequest Digoxin 0.125 MG Oral Tablet 08-27-1991
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 08-27-1991
Encounter General examination of patient (procedure) 09-01-1992
MedicationRequest Verapamil Hydrochloride 40 MG 09-01-1992
MedicationRequest lisinopril 10 MG Oral Tablet 09-01-1992
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-01-1992
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-01-1992
Encounter General examination of patient (procedure) 09-07-1993
MedicationRequest Verapamil Hydrochloride 40 MG 09-07-1993
MedicationRequest lisinopril 10 MG Oral Tablet 09-07-1993
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-07-1993
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-07-1993
Encounter Outpatient procedure 09-03-1993
MedicationRequest Verapamil Hydrochloride 40 MG 09-07-1993
MedicationRequest lisinopril 10 MG Oral Tablet 09-07-1993
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-07-1993
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-07-1993
Encounter General examination of patient (procedure) 09-13-1994
MedicationRequest Verapamil Hydrochloride 40 MG 09-13-1994
MedicationRequest lisinopril 10 MG Oral Tablet 09-13-1994
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-13-1994
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-13-1994
Encounter General examination of patient (procedure) 09-19-1995
MedicationRequest Verapamil Hydrochloride 40 MG 09-19-1995
MedicationRequest lisinopril 10 MG Oral Tablet 09-19-1995
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-19-1995
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-19-1995
Encounter General examination of patient (procedure) 09-24-1996
MedicationRequest Verapamil Hydrochloride 40 MG 09-24-1996
MedicationRequest lisinopril 10 MG Oral Tablet 09-24-1996
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-24-1996
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-24-1996
Encounter General examination of patient (procedure) 09-30-1997
MedicationRequest Verapamil Hydrochloride 40 MG 09-30-1997
MedicationRequest lisinopril 10 MG Oral Tablet 09-30-1997
MedicationRequest Digoxin 0.125 MG Oral Tablet 09-30-1997
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 09-30-1997
Encounter General examination of patient (procedure) 10-06-1998
MedicationRequest Verapamil Hydrochloride 40 MG 10-06-1998
MedicationRequest lisinopril 10 MG Oral Tablet 10-06-1998
MedicationRequest Digoxin 0.125 MG Oral Tablet 10-06-1998
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 10-06-1998
Encounter General examination of patient (procedure) 10-12-1999
MedicationRequest Verapamil Hydrochloride 40 MG 10-12-1999
MedicationRequest lisinopril 10 MG Oral Tablet 10-12-1999
MedicationRequest Digoxin 0.125 MG Oral Tablet 10-12-1999
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 10-12-1999
Encounter General examination of patient (procedure) 10-17-2000
MedicationRequest Verapamil Hydrochloride 40 MG 10-17-2000
MedicationRequest lisinopril 10 MG Oral Tablet 10-17-2000
MedicationRequest Digoxin 0.125 MG Oral Tablet 10-17-2000
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 10-17-2000
Encounter General examination of patient (procedure) 10-23-2001
MedicationRequest Verapamil Hydrochloride 40 MG 10-23-2001
MedicationRequest lisinopril 10 MG Oral Tablet 10-23-2001
MedicationRequest Digoxin 0.125 MG Oral Tablet 10-23-2001
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 10-23-2001
Encounter General examination of patient (procedure) 10-29-2002
MedicationRequest Verapamil Hydrochloride 40 MG 10-23-2002
MedicationRequest lisinopril 10 MG Oral Tablet 10-23-2002
MedicationRequest Digoxin 0.125 MG Oral Tablet 10-23-2002
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 10-23-2002
Encounter General examination of patient (procedure) 11-04-2003
MedicationRequest Verapamil Hydrochloride 40 MG 11-04-2003
MedicationRequest lisinopril 10 MG Oral Tablet 11-04-2003
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-04-2003
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-04-2003
Encounter General examination of patient (procedure) 11-09-2004
MedicationRequest Verapamil Hydrochloride 40 MG 11-03-2004
MedicationRequest lisinopril 10 MG Oral Tablet 11-03-2004
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-03-2004
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-03-2004
Encounter Encounter for problem 11-03-2004
Condition Neoplasm of prostate 11-03-2004
Condition Carcinoma in situ of prostate (disorder) 11-03-2004
MedicationRequest 1 ML DOCEtaxel 20 MG/ML Injection 11-03-2004
MedicationRequest 0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe 11-03-2004
MedicationRequest Verapamil Hydrochloride 40 MG 11-09-2004
MedicationRequest lisinopril 10 MG Oral Tablet 11-09-2004
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-09-2004
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-09-2004
Encounter General examination of patient (procedure) 11-15-2005
MedicationRequest Verapamil Hydrochloride 40 MG 11-15-2005
MedicationRequest lisinopril 10 MG Oral Tablet 11-15-2005
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-15-2005
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-15-2005
Encounter General examination of patient (procedure) 11-21-2006
MedicationRequest Verapamil Hydrochloride 40 MG 11-21-2006
MedicationRequest lisinopril 10 MG Oral Tablet 11-21-2006
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-21-2006
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-21-2006
Encounter General examination of patient (procedure) 11-27-2007
MedicationRequest Verapamil Hydrochloride 40 MG 11-27-2007
MedicationRequest lisinopril 10 MG Oral Tablet 11-27-2007
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-27-2007
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-27-2007
Encounter General examination of patient (procedure) 12-02-2008
MedicationRequest Verapamil Hydrochloride 40 MG 12-02-2008
MedicationRequest lisinopril 10 MG Oral Tablet 12-02-2008
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-02-2008
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-02-2008
Encounter General examination of patient (procedure) 12-08-2009
MedicationRequest Verapamil Hydrochloride 40 MG 12-08-2009
MedicationRequest lisinopril 10 MG Oral Tablet 12-08-2009
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-08-2009
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-08-2009
Encounter General examination of patient (procedure) 12-14-2010
MedicationRequest Verapamil Hydrochloride 40 MG 12-14-2010
MedicationRequest lisinopril 10 MG Oral Tablet 12-14-2010
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-14-2010
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-14-2010
Encounter Encounter for symptom 11-02-2011
MedicationRequest Verapamil Hydrochloride 40 MG 11-08-2011
MedicationRequest lisinopril 10 MG Oral Tablet 11-08-2011
MedicationRequest Digoxin 0.125 MG Oral Tablet 11-08-2011
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 11-08-2011
Encounter General examination of patient (procedure) 12-20-2011
Observation Body Height 12-20-2011 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-20-2011 3 {score}
Observation Body Weight 12-20-2011 99.5 kg
Observation Body Mass Index 12-20-2011 30.08 kg/m2
Observation Blood Pressure 12-20-2011
Observation Heart rate 12-20-2011 85 /min
Observation Respiratory rate 12-20-2011 15 /min
Observation Glucose 12-20-2011 79.86 mg/dL
Observation Urea Nitrogen 12-20-2011 14.58 mg/dL
Observation Creatinine 12-20-2011 0.97 mg/dL
Observation Calcium 12-20-2011 8.87 mg/dL
Observation Sodium 12-20-2011 137.8 mmol/L
Observation Potassium 12-20-2011 4.34 mmol/L
Observation Chloride 12-20-2011 109.28 mmol/L
Observation Carbon Dioxide 12-20-2011 25.24 mmol/L
Observation Tobacco smoking status NHIS 12-20-2011
Observation Hemoglobin A1c/Hemoglobin.total in Blood 12-20-2011 6.06 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-20-2011
Observation Fall risk total [Morse Fall Scale] 12-20-2011 30 {#}
Observation Fall risk level [Morse Fall Scale] 12-20-2011
Observation Total score [HARK] 12-20-2011 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 12-20-2011 1 {score}
Procedure Electrical cardioversion 12-20-2011
Procedure Assessment of health and social care needs (procedure) 12-20-2011
Procedure Assessment using Morse Fall Scale (procedure) 12-20-2011
Procedure Screening for domestic abuse (procedure) 12-20-2011
Procedure Depression screening (procedure) 12-20-2011
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-20-2011
MedicationRequest Verapamil Hydrochloride 40 MG 12-20-2011
MedicationRequest lisinopril 10 MG Oral Tablet 12-20-2011
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-20-2011
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-20-2011
Encounter Emergency room admission (procedure) 01-04-2012
Observation DXA [T-score] Bone density 01-04-2012 0.30878 {T-score}
Procedure Ankle X-ray 01-04-2012
Procedure Bone immobilization 01-04-2012
Procedure Bone density scan (procedure) 01-04-2012
MedicationRequest Acetaminophen 325 MG / oxyCODONE Hydrochloride 5 MG Oral Tablet 01-04-2012
MedicationRequest Acetaminophen 325 MG Oral Tablet 01-04-2012
Encounter Encounter for 'check-up' 04-19-2012
Encounter Encounter Inpatient 09-01-2012
Condition Chronic intractable migraine without aura 09-01-2012
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 09-01-2012 7 {score}
MedicationRequest Acetaminophen 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet 09-01-2012
Encounter General examination of patient (procedure) 12-25-2012
Observation Body Height 12-25-2012 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-25-2012 0 {score}
Observation Body Weight 12-25-2012 95 kg
Observation Body Mass Index 12-25-2012 28.7 kg/m2
Observation Blood Pressure 12-25-2012
Observation Heart rate 12-25-2012 93 /min
Observation Respiratory rate 12-25-2012 16 /min
Observation Glucose 12-25-2012 71.92 mg/dL
Observation Urea Nitrogen 12-25-2012 13.4 mg/dL
Observation Creatinine 12-25-2012 0.91 mg/dL
Observation Calcium 12-25-2012 9.63 mg/dL
Observation Sodium 12-25-2012 143.84 mmol/L
Observation Potassium 12-25-2012 5.11 mmol/L
Observation Chloride 12-25-2012 105.73 mmol/L
Observation Carbon Dioxide 12-25-2012 21.22 mmol/L
Observation Leukocytes [#/volume] in Blood by Automated count 12-25-2012 7.5762 10*3/uL
Observation Erythrocytes [#/volume] in Blood by Automated count 12-25-2012 4.7567 10*6/uL
Observation Hemoglobin [Mass/volume] in Blood 12-25-2012 14.968 g/dL
Observation Hematocrit [Volume Fraction] of Blood by Automated count 12-25-2012 47.17 %
Observation MCV [Entitic volume] by Automated count 12-25-2012 90.728 fL
Observation MCH [Entitic mass] by Automated count 12-25-2012 27.856 pg
Observation MCHC [Mass/volume] by Automated count 12-25-2012 34.752 g/dL
Observation Erythrocyte distribution width [Entitic volume] by Automated count 12-25-2012 44.398 fL
Observation Platelets [#/volume] in Blood by Automated count 12-25-2012 166.05 10*3/uL
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 12-25-2012 483.35 fL
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 12-25-2012 11.521 fL
Observation Tobacco smoking status NHIS 12-25-2012
Observation Hemoglobin A1c/Hemoglobin.total in Blood 12-25-2012 6.25 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-25-2012
Observation Fall risk total [Morse Fall Scale] 12-25-2012 80 {#}
Observation Fall risk level [Morse Fall Scale] 12-25-2012
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 12-25-2012 6 {score}
Observation Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 12-25-2012 5 {score}
Procedure Electrical cardioversion 12-25-2012
Procedure Assessment of health and social care needs (procedure) 12-25-2012
Procedure Assessment using Morse Fall Scale (procedure) 12-25-2012
Procedure Depression screening (procedure) 12-25-2012
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-25-2012
Procedure Depression screening using Patient Health Questionnaire Nine Item score (procedure) 12-25-2012
MedicationRequest Verapamil Hydrochloride 40 MG 12-25-2012
MedicationRequest lisinopril 10 MG Oral Tablet 12-25-2012
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-25-2012
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-25-2012
Immunization Influenza, seasonal, injectable, preservative free 12-25-2012
Immunization Td (adult) preservative free 12-25-2012
Encounter General examination of patient (procedure) 12-31-2013
Observation Body Height 12-31-2013 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 12-31-2013 3 {score}
Observation Body Weight 12-31-2013 93 kg
Observation Body Mass Index 12-31-2013 28.09 kg/m2
Observation Blood Pressure 12-31-2013
Observation Heart rate 12-31-2013 80 /min
Observation Respiratory rate 12-31-2013 14 /min
Observation Glucose 12-31-2013 91.1 mg/dL
Observation Urea Nitrogen 12-31-2013 18.46 mg/dL
Observation Creatinine 12-31-2013 0.86 mg/dL
Observation Calcium 12-31-2013 8.95 mg/dL
Observation Sodium 12-31-2013 140.99 mmol/L
Observation Potassium 12-31-2013 4.68 mmol/L
Observation Chloride 12-31-2013 103.73 mmol/L
Observation Carbon Dioxide 12-31-2013 21.33 mmol/L
Observation Total Cholesterol 12-31-2013 196.79 mg/dL
Observation Triglycerides 12-31-2013 105.36 mg/dL
Observation Low Density Lipoprotein Cholesterol 12-31-2013 100.53 mg/dL
Observation High Density Lipoprotein Cholesterol 12-31-2013 75.19 mg/dL
Observation Tobacco smoking status NHIS 12-31-2013
Observation Hemoglobin A1c/Hemoglobin.total in Blood 12-31-2013 5.81 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 12-31-2013
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 12-31-2013 1 {score}
Observation Fall risk total [Morse Fall Scale] 12-31-2013 101 {#}
Observation Fall risk level [Morse Fall Scale] 12-31-2013
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 12-31-2013 2 {score}
Procedure Electrical cardioversion 12-31-2013
Procedure Assessment of health and social care needs (procedure) 12-31-2013
Procedure Assessment of anxiety (procedure) 12-31-2013
Procedure Assessment using Morse Fall Scale (procedure) 12-31-2013
Procedure Depression screening (procedure) 12-31-2013
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-31-2013
MedicationRequest Verapamil Hydrochloride 40 MG 12-31-2013
MedicationRequest lisinopril 10 MG Oral Tablet 12-31-2013
MedicationRequest Digoxin 0.125 MG Oral Tablet 12-31-2013
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 12-31-2013
Immunization Influenza, seasonal, injectable, preservative free 12-31-2013
Encounter General examination of patient (procedure) 01-06-2015
Condition Victim of intimate partner abuse (finding) 01-06-2015
Observation Body Height 01-06-2015 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-06-2015 1 {score}
Observation Body Weight 01-06-2015 95.2 kg
Observation Body Mass Index 01-06-2015 28.76 kg/m2
Observation Blood Pressure 01-06-2015
Observation Heart rate 01-06-2015 81 /min
Observation Respiratory rate 01-06-2015 13 /min
Observation Glucose 01-06-2015 83.99 mg/dL
Observation Urea Nitrogen 01-06-2015 7.66 mg/dL
Observation Creatinine 01-06-2015 0.97 mg/dL
Observation Calcium 01-06-2015 9.18 mg/dL
Observation Sodium 01-06-2015 139.61 mmol/L
Observation Potassium 01-06-2015 5.18 mmol/L
Observation Chloride 01-06-2015 101.3 mmol/L
Observation Carbon Dioxide 01-06-2015 21.97 mmol/L
Observation Tobacco smoking status NHIS 01-06-2015
Observation Hemoglobin A1c/Hemoglobin.total in Blood 01-06-2015 6.32 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-06-2015
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-06-2015 3 {score}
Observation Fall risk total [Morse Fall Scale] 01-06-2015 31 {#}
Observation Fall risk level [Morse Fall Scale] 01-06-2015
Observation Total score [HARK] 01-06-2015 2 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-06-2015 1 {score}
Procedure Electrical cardioversion 01-06-2015
Procedure Assessment of health and social care needs (procedure) 01-06-2015
Procedure Assessment of anxiety (procedure) 01-06-2015
Procedure Assessment using Morse Fall Scale (procedure) 01-06-2015
Procedure Screening for domestic abuse (procedure) 01-06-2015
Procedure Depression screening (procedure) 01-06-2015
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-06-2015
MedicationRequest Verapamil Hydrochloride 40 MG 01-06-2015
MedicationRequest lisinopril 10 MG Oral Tablet 01-06-2015
MedicationRequest Digoxin 0.125 MG Oral Tablet 01-06-2015
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 01-06-2015
Immunization Influenza, seasonal, injectable, preservative free 01-06-2015
Encounter General examination of patient (procedure) 01-12-2016
Observation Body Height 01-12-2016 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-12-2016 3 {score}
Observation Body Weight 01-12-2016 97.4 kg
Observation Body Mass Index 01-12-2016 29.43 kg/m2
Observation Blood Pressure 01-12-2016
Observation Heart rate 01-12-2016 62 /min
Observation Respiratory rate 01-12-2016 14 /min
Observation Glucose 01-12-2016 84.91 mg/dL
Observation Urea Nitrogen 01-12-2016 7.64 mg/dL
Observation Creatinine 01-12-2016 0.88 mg/dL
Observation Calcium 01-12-2016 9.71 mg/dL
Observation Sodium 01-12-2016 143.35 mmol/L
Observation Potassium 01-12-2016 4.6 mmol/L
Observation Chloride 01-12-2016 102.34 mmol/L
Observation Carbon Dioxide 01-12-2016 26.82 mmol/L
Observation Tobacco smoking status NHIS 01-12-2016
Observation Hemoglobin A1c/Hemoglobin.total in Blood 01-12-2016 6.28 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-12-2016
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-12-2016 2 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-12-2016 0 {score}
Procedure Electrical cardioversion 01-12-2016
Procedure Assessment of health and social care needs (procedure) 01-12-2016
Procedure Medication Reconciliation (procedure) 01-12-2016
Procedure Assessment of anxiety (procedure) 01-12-2016
Procedure Depression screening (procedure) 01-12-2016
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-12-2016
MedicationRequest Verapamil Hydrochloride 40 MG 01-12-2016
MedicationRequest lisinopril 10 MG Oral Tablet 01-12-2016
MedicationRequest Digoxin 0.125 MG Oral Tablet 01-12-2016
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 01-12-2016
Immunization Influenza, seasonal, injectable, preservative free 01-12-2016
Encounter Encounter for symptom 02-06-2016
Encounter General examination of patient (procedure) 01-17-2017
Observation Body Height 01-17-2017 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-17-2017 2 {score}
Observation Body Weight 01-17-2017 99.6 kg
Observation Body Mass Index 01-17-2017 30.1 kg/m2
Observation Blood Pressure 01-17-2017
Observation Heart rate 01-17-2017 64 /min
Observation Respiratory rate 01-17-2017 16 /min
Observation Glucose 01-17-2017 79.29 mg/dL
Observation Urea Nitrogen 01-17-2017 16.79 mg/dL
Observation Creatinine 01-17-2017 1.04 mg/dL
Observation Calcium 01-17-2017 9.16 mg/dL
Observation Sodium 01-17-2017 141.54 mmol/L
Observation Potassium 01-17-2017 3.76 mmol/L
Observation Chloride 01-17-2017 108.26 mmol/L
Observation Carbon Dioxide 01-17-2017 20.07 mmol/L
Observation Total Cholesterol 01-17-2017 196.3 mg/dL
Observation Triglycerides 01-17-2017 110.62 mg/dL
Observation Low Density Lipoprotein Cholesterol 01-17-2017 98.93 mg/dL
Observation High Density Lipoprotein Cholesterol 01-17-2017 75.24 mg/dL
Observation Tobacco smoking status NHIS 01-17-2017
Observation Hemoglobin A1c/Hemoglobin.total in Blood 01-17-2017 6.2 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-17-2017
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-17-2017 1 {score}
Observation Fall risk total [Morse Fall Scale] 01-17-2017 11 {#}
Observation Fall risk level [Morse Fall Scale] 01-17-2017
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-17-2017 0 {score}
Procedure Electrical cardioversion 01-17-2017
Procedure Assessment of health and social care needs (procedure) 01-17-2017
Procedure Medication Reconciliation (procedure) 01-17-2017
Procedure Assessment of anxiety (procedure) 01-17-2017
Procedure Assessment using Morse Fall Scale (procedure) 01-17-2017
Procedure Depression screening (procedure) 01-17-2017
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-17-2017
MedicationRequest Verapamil Hydrochloride 40 MG 01-17-2017
MedicationRequest lisinopril 10 MG Oral Tablet 01-17-2017
MedicationRequest Digoxin 0.125 MG Oral Tablet 01-17-2017
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 01-17-2017
Immunization Influenza, seasonal, injectable, preservative free 01-17-2017
Encounter General examination of patient (procedure) 01-23-2018
Observation Body Height 01-23-2018 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-23-2018 1 {score}
Observation Body Weight 01-23-2018 100.3 kg
Observation Body Mass Index 01-23-2018 30.31 kg/m2
Observation Blood Pressure 01-23-2018
Observation Heart rate 01-23-2018 71 /min
Observation Respiratory rate 01-23-2018 13 /min
Observation Glucose 01-23-2018 95.39 mg/dL
Observation Urea Nitrogen 01-23-2018 8.13 mg/dL
Observation Creatinine 01-23-2018 1.06 mg/dL
Observation Calcium 01-23-2018 9.02 mg/dL
Observation Sodium 01-23-2018 139.53 mmol/L
Observation Potassium 01-23-2018 4.52 mmol/L
Observation Chloride 01-23-2018 105.28 mmol/L
Observation Carbon Dioxide 01-23-2018 22.63 mmol/L
Observation Leukocytes [#/volume] in Blood by Automated count 01-23-2018 4.807 10*3/uL
Observation Erythrocytes [#/volume] in Blood by Automated count 01-23-2018 4.4219 10*6/uL
Observation Hemoglobin [Mass/volume] in Blood 01-23-2018 15.919 g/dL
Observation Hematocrit [Volume Fraction] of Blood by Automated count 01-23-2018 35.203 %
Observation MCV [Entitic volume] by Automated count 01-23-2018 85.301 fL
Observation MCH [Entitic mass] by Automated count 01-23-2018 27.235 pg
Observation MCHC [Mass/volume] by Automated count 01-23-2018 33.668 g/dL
Observation Erythrocyte distribution width [Entitic volume] by Automated count 01-23-2018 45.889 fL
Observation Platelets [#/volume] in Blood by Automated count 01-23-2018 370.8 10*3/uL
Observation Platelet distribution width [Entitic volume] in Blood by Automated count 01-23-2018 304.18 fL
Observation Platelet mean volume [Entitic volume] in Blood by Automated count 01-23-2018 9.6364 fL
Observation Tobacco smoking status NHIS 01-23-2018
Observation Hemoglobin A1c/Hemoglobin.total in Blood 01-23-2018 6.05 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-23-2018
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-23-2018 0 {score}
Observation Fall risk total [Morse Fall Scale] 01-23-2018 4 {#}
Observation Fall risk level [Morse Fall Scale] 01-23-2018
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-23-2018 0 {score}
Procedure Electrical cardioversion 01-23-2018
Procedure Assessment of health and social care needs (procedure) 01-23-2018
Procedure Assessment of anxiety (procedure) 01-23-2018
Procedure Assessment using Morse Fall Scale (procedure) 01-23-2018
Procedure Depression screening (procedure) 01-23-2018
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-23-2018
MedicationRequest Verapamil Hydrochloride 40 MG 01-23-2018
MedicationRequest lisinopril 10 MG Oral Tablet 01-23-2018
MedicationRequest Digoxin 0.125 MG Oral Tablet 01-23-2018
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 01-23-2018
Immunization Influenza, seasonal, injectable, preservative free 01-23-2018
Encounter General examination of patient (procedure) 01-29-2019
Condition Stress (finding) 01-29-2019
Observation Body Height 01-29-2019 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 01-29-2019 2 {score}
Observation Body Weight 01-29-2019 100.3 kg
Observation Body Mass Index 01-29-2019 30.31 kg/m2
Observation Blood Pressure 01-29-2019
Observation Heart rate 01-29-2019 87 /min
Observation Respiratory rate 01-29-2019 14 /min
Observation Glucose 01-29-2019 70.95 mg/dL
Observation Urea Nitrogen 01-29-2019 14.84 mg/dL
Observation Creatinine 01-29-2019 0.86 mg/dL
Observation Calcium 01-29-2019 9.66 mg/dL
Observation Sodium 01-29-2019 138.13 mmol/L
Observation Potassium 01-29-2019 4.07 mmol/L
Observation Chloride 01-29-2019 102.25 mmol/L
Observation Carbon Dioxide 01-29-2019 23.25 mmol/L
Observation Tobacco smoking status NHIS 01-29-2019
Observation Hemoglobin A1c/Hemoglobin.total in Blood 01-29-2019 6.26 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 01-29-2019
Observation Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 01-29-2019 3 {score}
Observation Total score [HARK] 01-29-2019 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 01-29-2019 1 {score}
Procedure Catheter ablation of tissue of heart 01-29-2019
Procedure Assessment of health and social care needs (procedure) 01-29-2019
Procedure Assessment of anxiety (procedure) 01-29-2019
Procedure Screening for domestic abuse (procedure) 01-29-2019
Procedure Depression screening (procedure) 01-29-2019
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 01-29-2019
MedicationRequest Verapamil Hydrochloride 40 MG 01-29-2019
MedicationRequest lisinopril 10 MG Oral Tablet 01-29-2019
MedicationRequest Digoxin 0.125 MG Oral Tablet 01-29-2019
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 01-29-2019
Immunization Influenza, seasonal, injectable, preservative free 01-29-2019
Encounter General examination of patient (procedure) 02-04-2020
Observation Body Height 02-04-2020 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-04-2020 0 {score}
Observation Body Weight 02-04-2020 100.3 kg
Observation Body Mass Index 02-04-2020 30.31 kg/m2
Observation Blood Pressure 02-04-2020
Observation Heart rate 02-04-2020 68 /min
Observation Respiratory rate 02-04-2020 15 /min
Observation Glucose 02-04-2020 75.29 mg/dL
Observation Urea Nitrogen 02-04-2020 19.27 mg/dL
Observation Creatinine 02-04-2020 0.85 mg/dL
Observation Calcium 02-04-2020 9.78 mg/dL
Observation Sodium 02-04-2020 136.29 mmol/L
Observation Potassium 02-04-2020 4.49 mmol/L
Observation Chloride 02-04-2020 102.34 mmol/L
Observation Carbon Dioxide 02-04-2020 26.72 mmol/L
Observation Total Cholesterol 02-04-2020 177.59 mg/dL
Observation Triglycerides 02-04-2020 100.67 mg/dL
Observation Low Density Lipoprotein Cholesterol 02-04-2020 97.24 mg/dL
Observation High Density Lipoprotein Cholesterol 02-04-2020 60.22 mg/dL
Observation Tobacco smoking status NHIS 02-04-2020
Observation Hemoglobin A1c/Hemoglobin.total in Blood 02-04-2020 6.29 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-04-2020
Observation Total score [HARK] 02-04-2020 0 {score}
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-04-2020 1 {score}
Procedure Electrical cardioversion 02-04-2020
Procedure Assessment of health and social care needs (procedure) 02-04-2020
Procedure Screening for domestic abuse (procedure) 02-04-2020
Procedure Depression screening (procedure) 02-04-2020
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-04-2020
MedicationRequest Verapamil Hydrochloride 40 MG 02-04-2020
MedicationRequest lisinopril 10 MG Oral Tablet 02-04-2020
MedicationRequest Digoxin 0.125 MG Oral Tablet 02-04-2020
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 02-04-2020
Immunization Influenza, seasonal, injectable, preservative free 02-04-2020
Encounter General examination of patient (procedure) 02-09-2021
Condition Alzheimer's disease (disorder) 02-09-2021
Condition Part-time employment (finding) 02-09-2021
Observation Total score [MMSE] 02-09-2021 20.546 {score}
Observation Body Height 02-09-2021 181.9 cm
Observation Pain severity - 0-10 verbal numeric rating [Score] - Reported 02-09-2021 2 {score}
Observation Body Weight 02-09-2021 100.3 kg
Observation Body Mass Index 02-09-2021 30.31 kg/m2
Observation Blood Pressure 02-09-2021
Observation Heart rate 02-09-2021 60 /min
Observation Respiratory rate 02-09-2021 15 /min
Observation Glucose 02-09-2021 92.98 mg/dL
Observation Urea Nitrogen 02-09-2021 18.31 mg/dL
Observation Creatinine 02-09-2021 1.06 mg/dL
Observation Calcium 02-09-2021 10.06 mg/dL
Observation Sodium 02-09-2021 140.74 mmol/L
Observation Potassium 02-09-2021 4.79 mmol/L
Observation Chloride 02-09-2021 107.09 mmol/L
Observation Carbon Dioxide 02-09-2021 28.72 mmol/L
Observation Tobacco smoking status NHIS 02-09-2021
Observation Hemoglobin A1c/Hemoglobin.total in Blood 02-09-2021 5.81 %
Observation Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences [PRAPARE] 02-09-2021
Observation Fall risk total [Morse Fall Scale] 02-09-2021 45 {#}
Observation Fall risk level [Morse Fall Scale] 02-09-2021
Observation Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 02-09-2021 0 {score}
Procedure Electrical cardioversion 02-09-2021
Procedure Assessment of health and social care needs (procedure) 02-09-2021
Procedure Assessment using Morse Fall Scale (procedure) 02-09-2021
Procedure Depression screening (procedure) 02-09-2021
Procedure Depression screening using Patient Health Questionnaire Two-Item score (procedure) 02-09-2021
MedicationRequest Verapamil Hydrochloride 40 MG 02-09-2021
MedicationRequest lisinopril 10 MG Oral Tablet 02-09-2021
MedicationRequest Digoxin 0.125 MG Oral Tablet 02-09-2021
MedicationRequest Warfarin Sodium 5 MG Oral Tablet 02-09-2021
MedicationRequest Galantamine 4 MG Oral Tablet 02-09-2021
Immunization Influenza, seasonal, injectable, preservative free 02-09-2021
Encounter Administration of vaccine to produce active immunity (procedure) 05-04-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 05-04-2021
Encounter Administration of vaccine to produce active immunity (procedure) 05-25-2021
Immunization SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 05-25-2021
